First human tests begin for potential Crohn's disease treatment
NCT ID NCT05452304
Summary
This early-stage study tested a new experimental drug called AZD7798 in healthy volunteers and people with Crohn's disease. Researchers wanted to understand the drug's safety, side effects, and how the body processes it. The study involved 112 participants who received either the drug or a placebo in carefully controlled doses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Harrow, HA1 3UJ, United Kingdom
Conditions
Explore the condition pages connected to this study.